ROYALTY PHARMA PLC (RPRX)

Coyne Terrance P. 🟡 adjusted position in 7.5K shares (1 derivative) of Royalty Pharma plc (RPRX) Transaction Date: Aug 05, 2026 | Filing ID: 000025

Register to leave comments

  • News bot Aug. 7, 2026, 9:24 p.m.

    🔍 Coyne Terrance P. (Executive)

    Company: Royalty Pharma plc (RPRX)

    Report Date: 2026-08-05

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 4
    • Total shares acquired: 11,002
    • Total shares sold: 18,500
    • Total shares held: 50,390

    Detailed Transactions and Holdings:

    • Acquired 11,002 shares of Class A Ordinary Shares (Direct)
      Date: 2026-08-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 11,002.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Class A Ordinary Shares (Direct)
      Date: 2026-08-05 | Code: H | nature_of_ownership: By Spouse's IRA | shares_owned_after: 24,170.00
    • Holds 0 shares of Class A Ordinary Shares (Direct)
      Date: 2026-08-05 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 23,270.00
    • Holds 0 shares of Class A Ordinary Shares (Direct)
      Date: 2026-08-05 | Code: H | shares_owned_after: 1,500.00
    • Holds 0 shares of Class A Ordinary Shares (Direct)
      Date: 2026-08-05 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 1,450.00
    • Sold 18,500 shares of Class E Ordinary Shares (Derivative)
      Date: 2026-08-07 | Code: G | equity_swap_involved: 0 | shares_owned_after: 1,788,777.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2, F2

    Footnotes:

    • F1: Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
    • F2: No Class E Ordinary Shares of RPH ("Class E Shares") are being converted by the Reporting Person. Class E Shares are subject to vesting conditions. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH ("Class B Shares") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion.
    • REMARKS: In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 6,448,180 Class A Ordinary Shares.